Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids

<table>Time course of the apoptotic rate and cell-cycle distribution after treatment of Jurkat cells with 50 <i>μ</i>M QC for 24 h (Q50, solid circles), 100 <i>μ</i>M H<sub>2</sub>O<sub>2</sub> for 20 min. (H100, open circles), or combination of the two (50 <i>μ</i>M QC preincubation followed by addition of 100 <i>μ</i>M H<sub>2</sub>O<sub>2</sub> for 20 min.; treatment denoted as Q50 + H100, gray circles). Apoptotic rates (a), G<sub>0</sub>/G<sub>1</sub> (b), S phase (c), and G<sub>2</sub>/M (d) cell fractions are indicated. The dashed line represents the average obtained from control cell samples.</table>

Oxidative Medicine and Cellular Longevity

fig2

Figure 2

Figure 2: Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids 

Figure 2 | Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids 